INTRODUCTION
Nowadays obesity has emerged as a major health problem and risk factor for various disorders worldwide. Obesity is defined as a disease process characterized by excessive body fat accumulation with multiple organ-specific consequences. The prevalence of obesity is increasing to epidemic proportions globally (Ogden et al., 2012) .
Obesity is associated with a multitude of adverse health effects. Central or visceral fat in obesity pours out free fatty acids and increases insulin resistance.
The adipose cells secrete multiple hormones, known as 'adipokines,' and arkers of inflammation. Obesity is associated with a higher risk of diabetes, hypertriglyceridemia, decreased high-density lipoprotein (HDL) cholesterol, hypertension, stroke, proteinuria, gallstones, fatty change in the liver, nonalcoholic steatohepatitis, pancreatitis, venous thrombosis, hypoventilation syndrome, and osteoarthritis (Kumari et al., 2010; Shen et al., 2010) . Other conditions for which obesity poses an increased risk include sleep apnea, asthma, stress incontinence, depression, and several types of cancer (Gaby, 2011) .
Obesity has an immense impact globally in terms of human suffering and economic burden, resulting from the chronic disease and disability associated with obesity. The conventional treatment for obesity includes decreasing caloric intake and increasing physical activity, that is, 'diet and exercise.' Medications have also been utilized. However, the longterm success rate of most weight loss programs is very low (Gaby, 2011) .
In many cultures of the world, herbal remedies are increasingly being employed in an attempt to achieve the same purpose. In India, for instance, the leaf of Moringa oleifera Lam is claimed to possess a cholesterolreducing effect, and is used to treat patients with heart disease and obesity; for this reason, it was decided to resolve this claim by investigating the effects of the crude extract of leaves of Moringa oleifera Lam on the serum, liver and kidney cholesterol; as well as the effect on serum total protein and albumin was also examined in the same animal model. (Ghasi et al. 2000) .
Moringa oleifera (Moringaceae) has been recognized as it is containing a great number of bioactive compounds. The most used parts of the plant are the leaves, which are rich in vitamins, carotenoids, polyphenols, phenolic acids, flavonoids, alkaloids, glucosinolates, isothiocyanates, tannins and saponins. The high number of bioactive compounds might explain the pharmacological properties of Moringa. Many studies, in vitro and in vivo, have confirmed these pharmacological properties. The roots, bark, gum, leaf, fruit (pods), flowers, seed, and seed oil of MO are reported to have various biological activities, including protection against gastric ulcers, antidiabetic, hypotensive and antiinflammatory effects. It has also been shown to improve hepatic and renal functions and the regulation of thyroid hormone status. MO also protect against oxidative stress, inflammation, hepatic fibrosis, liver damage, hypercholesterolemia, bacterial activity, cancer and liver injury (Vergara-Jimenez et al., 2017 (Marrufo et al 2013) . The main objective of this study was to assess the ameliorating and thermogenesis efficiency of Moringa aqueous extract of dry leaves on obese modeled rats in a trial for managing massive body weight gain and protecting against its complication.
MATERIALS AND METHODS Herb Extraction:
This study dealt with the aqueous extract of the herb rather than that of organic solvents; this due to the possible effects of the organic solvents on the conformation and configuration structure of the extract components. Moringa oleifera Lam (Moringaceae) is purchased from the stores of Abd ElRahman Harraz (Bab El-Khalk zone, Cairo, Egypt), and was identified by special botanists, botany department, faculty of science Al Azhar university and was found to carry taxonomic serial number (TSN 503874).
Moringa Aqueous Extract Preparation:
Moringa aqueous extracts (MAE) was carried out according to the method of Berkovich et al. (2013) ; after grinding of Moringa oleifera dry leaves, a specimen of the powdered leaves was soaked with distilled water (1.25, W:W) in a glass conical flask for three hours, then immerse the container in a boiling water bath for 40 min. After filtration, the solid residues were subjected to the same process once again, and then the two water fractions were combined and re-filtered through Whatman No.1 filter paper (Whatman International Ltd, Maidstone, England). The filtrate was subjected to lypholyzation process through freeze drier (Snijders Scientific-tilburg, Holland) under pressure, 0.1 to 0.5 mbar and temperature -35 to -41°C conditions. The dry extract was stored at 4°C until used.
Determination of Total Extract Yield:
The combined extracts were transferred to a quick fit round bottom flask with a known weight (W1), then freeze-dried and weighed again (W2). Finally, the yield was calculated from the following formula: Extract yield (g/ g crude herb) = (W2 −W1)/W3 Where, W1 is the weight of clear and dry quick fit flask in grams, W2 is the weight of the flask after lypholization in grams, and W3 is the weight of the crude powdered herb in grams.
Determination of Total Phenolics Content:
The content of total phenolic compounds in the aqueous extract was analyzed spectrophotometrically using modified Folin-Ciocalteu colorimetric method of Jayaprakasha and Jaganmohan (2000) . In brief, 5 mg of the extract was dissolved in a 10 ml mixture of acetone and water (6:4 v/v). -Samples (0.2 ml) mixed with 1.0 ml of 10-folds diluted Folin-Ciocalteu reagent and 0.8 ml of sodium carbonate solution (7.5%). After 30 min at room temperature, the absorbance was measured at 765 nm using UV -160 1PC UV-visible spectrophotometer (Shimadzu, Japan).Total phenolic content as catechin equivalents (CE) was monitored from standard curve.
Radical Scavenging Activity (RSA):
The capacity of antioxidants in the extracts to quench DPPH radical was determined using the method of Nogala-Kalucka et al. (2005) . In this method, dissolve a certain weight of the extract in methanol (MeOH) to obtain a concentration of 200 ppm. A volume of 200µl from this solution was made up to 4 ml by MeOH. Add 1 ml of DPPH (6.09 x 10 -5 mol/l) solution (in MeOH), and after 10 minutes the absorbances of both tested and control sample [1 ml of DPPH solution (6.09 x 10 -5 mol/l) and 4 Noeman et al. (2011) . The weight and nose-anus length of each rat of both control and obese groups were measured at the start of the experiment and after seven weeks. BMI was determined by dividing the weight (g) by the square of the nose-anus length (cm 2 ). Animals with BMI greater than 0.68 g/cm 2 were considered obese as previously described by Novelli et al. (2007) . Rats that recorded BMI values below that level were excluded from the study. However, all rats of the obese group attained the target BMI and were all included.
Experimental Design:
After induction of obesity, both normal and obese rats were randomly divided into four groups (10 animals each); group 1 acted as control group and included healthy rats fed standard diet, group 2 included normal rats administrated with Moringa aqueous extract (1000 mg/kg b.w) and fed a standard diet, group 3 included untreated obese rats fed a high-fat diet, and group 4 included obese rats administrated with Moringa aqueous extract (1000 mg/kg b.w) and fed the same high-fat diet.
BMI and Body Weight Gain:
After induction of obesity, body weights, nose-anus length, weight gain and BMI of both obese and normal rat groups were recorded at start and end of the experiment. Both BMI value and body weight gain were calculated according to the formulae.
Body weight gain (%) = W1 is the animals' weight at the start. W2 is the animals' weight at the end of the experiment.
Blood and Tissue Sampling:
At the end of the study period (six weeks) and after recording the end weight and length of the animals, they were fasted overnight. Following diethyl ether anesthesia and using heparinized capillary tubes, blood specimens were withdrawn from the retro-orbital plexus into vacutainer collecting tubes and left 20 minutes to clot, then centrifuged at 3000 rpm for 10 minutes using cooling centrifuge (IEC centra-4R, International Equipment Co., USA). The sera were separated, divided into aliquots and stored at -80°C until biochemical measurements were carried out as soon as possible. After blood collection, the animals were rapidly sacrificed and a part of liver and whole heart of each animal was dissected out, washed with saline, dried, rolled in a piece of aluminum foil and stored at -80°C until homogenization and biochemical determinations; another part of each liver was preserved in a formalin-saline solution (10%); immediately processed, sectioned, stained and prepared for microscopic examination for histological changes.
Biochemical Determinations:
The activity of serum aminotransferases (ALAT and ASAT) was determined according to the kinetic method described by Schumann and Klauke (2003) and using instruction manual of reagent kits purchased from Human Gesell Schaft fur Biochemical und Diagnostic mbH, Germany. Serum GGT activity was measured according to the kinetic method described by IFCC (1983) using reagent kits purchased from BioSystems S.A. Costa Brava 30, Barcelona, Spain. Serum ALP activity was assayed according to the method of Moss and Henderson (1999) using the reagent kits purchased from DiaSys Diagnostic systems GmbH Germany. Serum total proteins and albumin concentrations were evaluated according to the photometric systems of Johnson et al. (1999) using reagent kits purchased from DiaSys Diagnostic systems GmbH Germany. Serum total cholesterol, triglycerides, LDL and HDL levels were determined according to the methods of Artiss and Zak (1997) , Cole et al. (1997) , Wieland and Seidel (1983) and Lopes-Virella et al. (1977) respectively, using reagent kits purchased from DiaSys Diagnostic System GmbH, Germany. Serum CK and LDH activities were determined according to the methods described by IFCC (1983) and Van der heiden (1994) , respectively using reagent kits purchased from Spectrum Diagnostic System MDSS GmbH, Egypt. Serum glucose level was determined, at time of sampling, according to the method described by Young (2001) using reagent kits obtained from Co., Dokki, Giza, Egypt. Urea and creatinine levels were assessed according to the methods described by Young (2001) Liver and heart GSH, SOD, CAT and NO levels were determined according to the methods of Beutler et al. (1963) , Aebi (1984) , Nishikimi et al. (1972) and Montgomery et al. (1961) respectively, using reagent kits obtained from Biodiagnostic Co., Dokki, Giza, Egypt.
Lipid Peroxidation (MDA):
Lipid peroxidation end product, malondialdehyde (MDA), level of both liver and heart homogenates was estimated chemically according to the method described by Ruiz-Larnea et al. (1994) on the base of MDA reaction with thiobarbituric acid (TBA) which forms a pink complex that can be measured photometrically. In this method 0.5 ml liver homogenate supernatant [1g Liver or heart tissue was homogenized in 10 ml phosphate buffer pH 7.4 and cool centrifuged at 5000 rpm for 10 minutes] was added to 4.5 ml working reagent [0.8 g TBA was dissolved in 100 ml perchloric acid (10%) and mixed with trichloroacetic acid (20%) in volume ratio 1 to 3, respectively]. In a boiling and shaking water bath, the sample-reagent mixture was left for 20 minutes, then carried out to cool at room temperature, and centrifuged for 5 minutes at 3000 rpm. The absorbance of the clear pink supernatant was measured photometrically at 535 nm against reagent blank (0.5 ml distilled water + 4.5 ml working reagent). The liver of different groups was sectioned into 5um thick paraffin sections, stained with hematoxylin and eosin (Drury and Wallington, 1980) and investigated by light microscope.
Statistical Analysis:
Comparisons between means were carried out using one-way ANOVA test followed by post hoc test (Duncan) at p≤ 0.05 (Steel & Torrie, 1960) . This analysis was computed using SAS program software; copyright (c) 1998 by SAS Institute Inc., Cary, NC, USA.
RESULTS
The yield amount, total phenolic content and radical scavenging activity of the powdered leaves of Moringa oleifera are shown in Figure 1 . The data revealed that obese rats recorded a significant elevation in body mass index (BMI) and body weight gain (BWG) when it was compared with control group. Fortunately, administration of obese rats with MAE resulted in a significant reduction in both BMI and BWG close to that of healthy control (Figures 2&3). Oral treatment of healthy animals with MAE neither deteriorate the activities of serum ALAT, ASAT, GGT and ALP nor the levels of total proteins, albumin, globulin, creatinine and urea. In contrast, obese animals' group recorded a significant increase in the activity of ALAT, ASAT, GGT and ALP, but neither deteriorate protein profile (total protein and albumin) nor kidney function (urea and creatinine), when both groups were compared with the healthy group. Favorably, treatment of the obese-rats group with MAE resulted in significant improvements in the activity of ALAT, ASAT, GGT and ALP in compare to obesity-rats' group (Table 1) . Table 1 : Activity of serum ALAT, ASAT, GGT and ALP and levels of total proteins, albumin, globulin, creatinine and urea of control, obese and MAE-treated animals groups.
Data are expressed as mean ± standard error of mean. All data were subjected to one-way ANOVA followed by post hoc test (Duncan) at p≤0.05. Within the same row, means with different superscript letters are significantly different. (MEA) is Moringa aqueous extract.
Regard to Table ( 2) and comparing with the normal control group, administration of rats with MO didn't disturb the level glucose or lipid profile or CK activity, but significantly reduced LDH activity. Counteract, obese rats group revealed a significant elevation in serum glucose, total cholesterol, triglycerides and LDL-c levels as well as CK and LDH activity matched with a significant reduction in HDL-c level. In comparison with obese group, treatment of obese rats with MAE resulted in significant improveements in serum levels of glucose, total cholesterol, triglycerides and LDL-c, and activity of serum CK and LDH Similarly, MAE never disturbs the serum irisin, TNFα, leptin and PON1 levels; while obese group showed a significant reduction in serum irisin as well as serum PON1 activity coupled with a significant elevation in serum TNFα and leptin levels when both rats groups were compared with control group. In additional the obese group, favorably treatment of obese animals with MAE significantly down-regulated the serum TNFα and leptin levels, and upregulated serum irisin level and PON1 activity (Table 3) . Comparing with normal rats, rats MAE neither adverse the livers' nor the hearts' oxidative stress voltage (NO and MDA) and the antioxidant battery (GSH, SOD and CAT), while obese rats group recorded a significant reduction in the values of the antioxidant battery (GSH, SOD and CAT) lined with a significant increase in the oxidative stress voltage (NO and MDA). In addition, MAE with high-fat diet resulted in a significant decrease in MDA and NO levels, matched with a significant increase in the values of the antioxidant battery (GSH as well as activity of SOD and CAT) in both liver and heart tissues when compared to the obese rats group Tables (4&5) . Table 5 : Levels of NO, MDA and GSH, and activity of SOD and CAT of heart tissue of control, obese and obese-treated animals groups.
Data are expressed as mean ± standard error of mean. All data were subjected to one-way ANOVA followed by post hoc test (Duncan) 
Histopathological Results Of Liver:
The microscopic examinations of the liver sections of the control, obese and obesetreated animals groups are illustrated in the Figures (4-9) . . Obesity is a major risk factor for augmented morbidity and mortality and is associated with various medical ailments (Wang and Lobstein 2006) . High fat diet-induced obesity has been considered as the most popular model among researchers due to its high similarity of mimicking the usual route of obesity episodes in human (Buettner et al. 2007 ) and so why it is considered as a reliable tool for studying obesity as they will readily gain weight when fed high-fat diets (Gajda 2009). Visceral adiposity is regarded as the direct link between obesity and several metabolic diseases, including risk of incidence of type 2 diabetes, atherosclerosis and hypertension, which are totally clustered under the clinical signs of the metabolic syndrome. This study confirmed the effectiveness of aqueous extract of M. oleifera in improving obesity and dyslipidemia occurred in obese rats after long-term treatment with MAE. (Ahmed et al. 2014) Moringa oleifera, an important multipurpose crop, is rich in various phytochemicals such as flavonoids, antioxidants, vitamins, minerals and carotenes.
Biochemical pathway analysis revealed that 28 identified metabolites were interconnected with 36 different pathways as well as related to different fatty acids and secondary metabolites synthesis biochemical pathways (Mahmud et al. 2014) .
Mostly, there is no suitable drug for treating diet-caused obesity; in regard of that, herbs are implicated as potential protective agents; therefore, the present study attempted to investigate the obesity controlling or thermoregulatory potential of Moringa oleifera in an obese-rat model.
Herein, this study showed that administration of normal rats with MAE never disturb either hepatic or kidney functions; this was monitored from the comparable values of ALAT, ASAT, GGT and ALP activities or total proteins, albumin, globulin, creatinine and urea levels as well as liver histological structures. This finding reflects the safe effect of MAE and is concomitant with Awodele et al. (2012) .
Results of this study declared that MAE has a hepato-nephro-protective therapeutic effect on obese rats; this was monitored from marked improvement in ALAT, ASAT, GGT and ALP activities or total proteins, albumin, globulin, as well as urea and creatinine levels in serum; this result goes in parallel with that of Yang et al. (2011) and Fakurazi et al. (2012) who attributed that to the antioxidant potential of MAE included phytochemicals.
Also, Buraimoh (2011) and Halaby et al. (2013) stated that this effect might be due to the potent antioxidant property of MAE contents (vitamins, a-tocopherol, ascorbic acid and 3-carotene, as well as glutathione) that act against oxidative stress, indicates its protective role against liver damage. This protective action may be also due to improvement of hepatic steatosis and fat accumulation in the liver (Hamaguchi et al., 2005 and Hanley et al., 2005) .
Fortunately, The present study recorded that treatment of obese rats with MAE significantly reduced the percentage of body weight gain and consequently BMI value as well as serum glucose, total cholesterol, triglycerides and LDL-cholesterol (those were elevated as a consequence of obesity) coupled with significant improvement in HDL (which was decreased due to obesity) showing apparent anti-obesity potential. This finding is in agreement with Mehta et al. (2003) , Jain et al. (2010) and Bais et al. (2014) . This improvement could be attributed to one or more mechanisms; MAE may reduce fat accumulation and free fatty acid, and/or it may increase energy expenditure-related fatty liver degradation and decreased fatty acid synthesis and fat intake in the liver. Also, the melatonin, an ingredients found in MAE, have a variety of important functions including direct free radical scavenging and antiinflammatory properties. Other bioactive constituents are found in MAE such as dopamine, dopa, coumarins, alkaloids and saponins, polyphenols, flavonoids and anthocyanin may influence glucose metabolism by several mechanisms such as inhibition of carbohydrate digestion and glucose absorption in the intestine, stimulation of insulin secretion from the pancreatic ß-cell, modulation of glucose release from liver, activation of insulin receptors and glucose uptake in the insulin-sensitive tissues, and modulation of hepatic glucose output. In addition, Moringa was found containing polyphenols that able to inhibit digestive enzymes such as salivary amylase, intestinal sucrase and a-glucosidase, consequently, reduce digestibility action and promotes pancreatic β-cells. It was suggested that Moringa oleifera also showed anti-dyslipidemia effects in human patients with hyperlipidemia (Nambiar et al., 2010) . It also improved the lipid profile in human with type 2 diabetes besides its beneficial effects on blood glucose (Kumari, 2010) .
Moringa oleifera significantly improved the lipid profile as it reduced total cholesterol, triglycerides and LDL-c besides the up-regulation of HDL-c; this finding was in accordance with Rojas and Gomes (2013) , Mehta et al. (2003) , Jain et al. (2010) , Bais et al. (2014) and Toma et al. (2015) , who showed that moringa oleifera decreased cholesterol, triglycerides, VLDL, LDL, and increased HDL in hypercholestermic rats; reflecting its efficiency for reducing the risk of cardiovascular disease. Obesity is a dominant risk factor of atherosclerosis as it can increase the cholesterol content of platelets, polymorphonuclear leukocytes and endothelial cells, so that endothelial and smooth muscle cells, neutrophils and platelets may be sources of free radicals and oxygen free radicals that have been implicated in the pathogenesis of hypercholesterolemic atherosclerosis and antioxidants suppress its development. Jaiswal et al. (2013) found that M. oleifera aqueous extract significantly increased the efficiency of several antioxidant agents such as glutathione reduced, superoxide dismutase, catalase, and reduced the oxidative agents such as MDA and NO in hepato-cardio tissues; these findings are in line with the results of our present study. Additionally, M. oleifera aqueous extract has contained the major groups of phytochemicals that contribute to the total antioxidant capacity of plant foods, mostly as polyphenols, flavonoids, carotenoids and antioxidant vitamins such as vitamins C and E (Lako et al., 2007) . Quercetin and kaempferol are the predominant flavonoids in M. oleifera. These compounds may act synergistically increasing the levels of antioxidant activity within these plant products and thereby, creating their desired therapeutic benefits (Manguro and Lemmen, 2007; Amaglo et al., 2010; Kasolo et al., 2010) ; this could interpret the potential of MAE to restore SOD and CAT activities as well as GSH, MDA and NO levels in hepato-cardio tissues. Moringa has been suggested as a contains, vitamins and carotenoids and these compounds mainly contribute to the antioxidant properties as well as other biological activities. In addition, it was evidenced that β-Carotene exist in MAE is efficiently converted into vitamin A in the body and has shown significant hepatoprotective effects. The main antioxidant activity that has been associated with the phenolic content ability is to scavenge free radical formation. The ability of a certain phenolic compound to bind to minerals may be beneficial in some cases, since copper and iron can be initiators of hydroxyl radical (Verma et al. 2009) , that findings confirm the high RSA of MAE herein our study.
Previously, it was stated that Moeinga inhibited production of macrophage inflammatory cytokine (TNF-α), which was induced by lipopolysaccharide (Kooltheat et al., 2014) , predicting its anti-inflammatory as reported by Waterman et al. (2014) who evidenced that Moeinga decreased the gene expression and production of inflammatory markers. Our results showed that MAE has antiinflammatory, thermogenic and antiatherosclerotic behaviors as it markedly reduced the inflammatory cytokine (TNF-α), elevated the thermogenic myokine (irisin) and raised the activity of the anti-atherosclerotic enzyme (PON1) in orally administration MAE with obese rats. This result is in agreement with Mahajan et al. (2007) and Rajanandh et al. (2012) also. Mahajan et al. (2007) reported that obesity leads to increased levels of monocytes that secrete increased amounts of TNF-α through upregulation of P38 MAPK, protein kinase (PKC-α and PKC-β), protein kinase (PKC-α and PKC-β), and nuclear factor (NF)-κB.
Irisin is secreted by muscle tissue during exercising (Boström et al. 2012) , and shows wide spread in body tissues. It has been shown that irisin exists not only in muscles but also in white fat tissue, liver, adult and fetal testes as well as in epididymis tissue (Aydin et al. 2014) . The irisin level increased 3-4 folds, and brown fat cell development accompanied with the decrease in white fat tissue (Boström et al. 2012) . Thus, irisin is defined as an anti-obesity myokin. Huh et al., 2012 stated that mechanisms underlying irisin combined with the increase of brown fat, may unravel the basis of physical exercise concluded a decrement in serum irisin level in obese animals, and he suggested that benefits on different conditions. Irisin seems to induce a brown-like phenotype in some white adipocytes.
PON1 is an antioxidant enzyme that inhibits oxidative modification of LDL and contributes to most of the antioxidative activity that has been attributed to HDL. PON1 can destroy active lipids in mildly oxidized LDL. (Aviram et al. 1999 ) Most serum PON1 is bound to the surface of HDL. The activity of PON1 (an antiatherosclerotic marker) was significantly lower in obese subjects than in controls. Several studies have suggested that there is an association between increased oxidative stress and BMI in obese animals (Keaney et al. 2003) . Rector et al. (2007) described lower serum PON1 activity with increased body weight. Sorenson et al. (1999) demonstrated that PON1 is a lipid-dependent enzyme; in fact, the confirmation of PON1 within the hydrophobic environment of HDL is crucial for its activity. Phospholipids, especially those with long fatty acid chains, stabilize PON1 enzyme and are required to bind PON1 to lipoprotein surface. The restored PON1 activity after treatment of obese rats with MAE could be attributed to the antioxidative and atherosclerotic properties of the bioactive compounds exist in Moringa as it significantly increased the efficiency of several antioxidant agents such as glutathione reduced, superoxide dismutase, catalase, and reduced the oxidative agents such as MDA and NO (Jaiswal et al., 2013) .
CONCLUSION
Moringa oleifera has many bioactive compounds with multiple pharmacological and medical properties; it can markedly downregulate BMI, atherosclerotic markers as well some well-known cardiovascular risk factors, and preferably up-regulates PON1 activity and irisin level. It can presumably be considered, as a supplement, for future long-term studies on prevention and treatment of obesity, dyslipidemia and atherosclerotic disorders.
